PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: <em>Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)</em>
AID  - 10.1136/annrheumdis-2019-216118corr1
DP  - 2020 Jun 01
TA  - Annals of the Rheumatic Diseases
PG  - e75--e75
VI  - 79
IP  - 6
4099  - http://ard.bmj.com/content/79/6/e75.short
4100  - http://ard.bmj.com/content/79/6/e75.full
SO  - Ann Rheum Dis2020 Jun 01; 79